The combined treatment of amyloid-beta(1-42)-stimulated bone marrow-derived dendritic cells plus splenocytes from young mice prevents the development of Alzheimer's disease in APPswe/PSENldE9 mice | |
Wang, Fei; Liu, Hanqiu; Shen, Xueyan; Ao, Hong; Moore, Nick; Gao, Lingling; Chen, Long; Hua, Heng; Maa, Huiying; Yang, Zixiao | |
刊名 | NEUROBIOLOGY OF AGING
![]() |
2015 | |
卷号 | 36期号:1 |
关键词 | Alzheimer's disease Bone marrow derived dendritic cell Immunotherapy Immune senescence |
ISSN号 | 0197-4580 |
URL标识 | 查看原文 |
语种 | 英语 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/4871270 |
专题 | 复旦大学上海医学院 |
推荐引用方式 GB/T 7714 | Wang, Fei,Liu, Hanqiu,Shen, Xueyan,et al. The combined treatment of amyloid-beta(1-42)-stimulated bone marrow-derived dendritic cells plus splenocytes from young mice prevents the development of Alzheimer's disease in APPswe/PSENldE9 mice[J]. NEUROBIOLOGY OF AGING,2015,36(1). |
APA | Wang, Fei.,Liu, Hanqiu.,Shen, Xueyan.,Ao, Hong.,Moore, Nick.,...&Liang, Chunmin.(2015).The combined treatment of amyloid-beta(1-42)-stimulated bone marrow-derived dendritic cells plus splenocytes from young mice prevents the development of Alzheimer's disease in APPswe/PSENldE9 mice.NEUROBIOLOGY OF AGING,36(1). |
MLA | Wang, Fei,et al."The combined treatment of amyloid-beta(1-42)-stimulated bone marrow-derived dendritic cells plus splenocytes from young mice prevents the development of Alzheimer's disease in APPswe/PSENldE9 mice".NEUROBIOLOGY OF AGING 36.1(2015). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论